miR-221 suppression through nanoparticle-based miRNA delivery system for hepatocellular carcinoma therapy and its diagnosis as a potential biomarker

Feng Li, Feiran Wang, Changlai Zhu, Qun Wei, Tianyi Zhang, You Lang Zhou

Open source

DOI
10.2147/ijn.s157805
Published
2018-04
Container
International Journal of Nanomedicine
Publisher
Informa UK Limited
Open access
unknown

Credibility signals

serious concern Score 23/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.2147/ijn.s157805,
  title = {miR-221 suppression through nanoparticle-based miRNA delivery system for hepatocellular carcinoma therapy and its diagnosis as a potential biomarker},
  author = {Feng Li and Feiran Wang and Changlai Zhu and Qun Wei and Tianyi Zhang and You Lang Zhou},
  year = {2018},
  journal = {International Journal of Nanomedicine},
  doi = {10.2147/ijn.s157805},
  url = {https://doi.org/10.2147/ijn.s157805}
}

RIS

TY  - JOUR
TI  - miR-221 suppression through nanoparticle-based miRNA delivery system for hepatocellular carcinoma therapy and its diagnosis as a potential biomarker
AU  - Feng Li
AU  - Feiran Wang
AU  - Changlai Zhu
AU  - Qun Wei
AU  - Tianyi Zhang
AU  - You Lang Zhou
PY  - 2018
JO  - International Journal of Nanomedicine
DO  - 10.2147/ijn.s157805
UR  - https://doi.org/10.2147/ijn.s157805
ER  - 

APA

Li, F., Wang, F., Zhu, C., Wei, Q., Zhang, T., & Zhou, Y. L. (2018). miR-221 suppression through nanoparticle-based miRNA delivery system for hepatocellular carcinoma therapy and its diagnosis as a potential biomarker. International Journal of Nanomedicine. https://doi.org/10.2147/ijn.s157805

Source records